Post Profile






Neoadjuvant immunotherapy prior to surgery is safe and feasible in early lung cancer

(European Society for Medical Oncology) Neoadjuvant immunotherapy with the PD-1 inhibitor nivolumab is safe and feasible prior to surgery for early lung cancer, researchers reported at the ESMO 2016 Congress in Copenhagen.
read more

share

Related Posts


Roche To Present Data Showing Progress In Treating Lung, Gastric And Brain Cancers At ESMO

Health : Medical News Today

More than 100 Roche abstracts have been accepted for the biggest cancer congress in Europe, the European Society for Medical Oncology (ESMO), which opens in Stockholm on Friday (12th September).

Biothera To Present Research Results At European Society For Medical Oncology World Gastrointestinal Congress

Health : Medical News Today

Biothera has been accepted to present data from its Phase II clinical trial in stage IV KRAS-mutant colorectal cancer at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer June 22-25 in B...

Nivolumab reduces symptoms in relapsed metastatic head and neck cancer

Health : EurekAlert: Health

(European Society for Medical Oncology) Nivolumab maintains function and reduces symptoms in treatment of relapsed metastatic head and neck cancer, according to results from the CheckMate 141 trial presented at the ESMO 2016 Congres...

Immunotherapy: Promising results in first & second line treatment of metastatic bladder cancer

Health : EurekAlert: Health

(European Society for Medical Oncology) Immunotherapy has shown promising results in first and second line treatment of metastatic bladder cancer in two phase II trials presented at the ESMO 2016 Congress in Copenhagen.

Neoadjuvant immunotherapy prior to surgery is safe, feasible in early lung cancer

Diseases & Conditions / Cancer : ScienceDaily: Cancer

Neoadjuvant immunotherapy with the PD-1 inhibitor nivolumab is safe and feasible prior to surgery for early lung cancer, researchers report.

Comments


Copyright © 2016 Regator, LLC